$1 Opportunity: “Buffett Stocks” to Buy Monday

[Zacks | Our Research. Your Success.] Under-the-Radar Plays for Monday {NAME}, I emailed you earlier today but didn't want this opportunity to pass without a final reminder. Tomorrow I'm posting a sharply undervalued stock that I believe Warren Buffett would have loved when he was aggressively amassing his multi-billion-dollar fortune. It’s an innovative biopharmaceutical company dominating its niche. Top-line sales are exploding higher, but shares are discounted about 20% after a recent selloff. This is your chance to get in on an exciting growth stock at irresistible value stock pricing. Plus, Zacks Rank timeliness can help us catch this stock at the right time - just as Wall Street is beginning to discover its true worth. Then we plan to ride along to its full gain potential. That's why stocks in the portfolio have surged as much as 213.2%... +290.3%... even +392.0%.¹ What to do now? Get set to be one of the first to see our new "Buffett Buy" as soon as it's posted Monday morning. In fact, look inside our Value Investor portfolio right away and [see its current live picks](. No need to hesitate. You can follow them for 30 days at a total cost of only $1, and there's not a cent of additional obligation. Today, as an added bonus, you can also download Zacks' just-updated Special Report, 5 Stocks Set to Double absolutely free. Recent editions of this report have pointed investors to some big winners, including Anavex Life Sciences, which jumped +359% in just 5 months. So don't miss out. Remember, this unique arrangement ends Sunday, August 29 - midnight tonight. [▶ See Stocks Now]( All the Best, [Tracey Ryniec - signature] Tracey Ryniec Editor of Value Investor ¹ The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. This free resource is being sent by [Zacks.com](. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". [( Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through June 28, 2021. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit [( for information about the performance numbers displayed above. Zacks Emails If you would prefer to not receive future profit-producing emails from [Zacks.com]( the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606